ConductScience.org, home

Paper3598607

Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.

Rodman JH and 5 others. J Clin Oncol, 1987. Cited by 123 papers, by iCite.

Cite this record

ConductScience Library. Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial. Papers, record 3598607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3598607

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.
PubMed
Journal
J Clin Oncol
PubMed
Year
1987
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
123
iCite
Relative citation ratio, by iCite
6.02
iCite
Revised in PubMed
2017-02-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rodman JHJ H
2Abromowitch MM
3Sinkule JAJ A
4Hayes FAF A
5Rivera GKG K
6Evans WEW E

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LeukemiaMajor topic
LymphomaMajor topic
NeuroblastomaMajor topic
PodophyllotoxinMajor topic
TeniposideMajor topic
Child
Drug Administration Schedule
Drug Evaluation
Humans
Infusions, Parenteral
Kinetics

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 20180NCI NIH HHSUnited StatesP01CA020180PubMed and NIHNIH RePORTER
CA 21765NCI NIH HHSUnited StatesP30CA021765PubMed and NIHNIH RePORTER
R01 CA 36401NCI NIH HHSUnited StatesR01CA036401PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.

PMIDTitleJournalYearIn PapersSource
29628775Prognostic significance of leukopenia during the induction phase in adult B cell acute lymphoblastic leukemia.Cancer Manag Res2018https://conductscience.org/library/papers/29628775PubMed
23116553Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients.Br J Clin Pharmacol2013https://conductscience.org/library/papers/23116553PubMed
18611060Population pharmacokinetics and pharmacodynamics for treatment optimization in clinical oncology.Clin Pharmacokinet2008https://conductscience.org/library/papers/18611060PubMed
16524321Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.Drug Saf2006https://conductscience.org/library/papers/16524321PubMed
11523723Measures of exposure versus measures of rate and extent of absorption.Clin Pharmacokinet2001https://conductscience.org/library/papers/11523723PubMed
11108434Pharmacokinetically guided administration of chemotherapeutic agents.Clin Pharmacokinet2000https://conductscience.org/library/papers/11108434PubMed
10803455Adaptive control methods for the dose individualisation of anticancer agents.Clin Pharmacokinet2000https://conductscience.org/library/papers/10803455PubMed
9878990Practical treatment guide for dose individualisation in cancer chemotherapy.Drugs1998https://conductscience.org/library/papers/9878990PubMed
9761935Benefits of pharmacological knowledge in the design and monitoring of cancer chemotherapy.Pathol Oncol Res1998https://conductscience.org/library/papers/9761935PubMed
9113440Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes.Clin Pharmacokinet1997https://conductscience.org/library/papers/9113440PubMed
8611379Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.Br J Cancer1996https://conductscience.org/library/papers/8611379PubMed
8335040Pharmacokinetic and pharmacodynamic data and models in clinical trials.Eur J Drug Metab Pharmacokinet1993https://conductscience.org/library/papers/8335040PubMed
8324869Disposition of total and unbound etoposide following high-dose therapy.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8324869PubMed
8229682Targeting the systemic exposure of teniposide in the population and the individual using a stochastic therapeutic objective.J Pharmacokinet Biopharm1993https://conductscience.org/library/papers/8229682PubMed
8070032Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8070032PubMed
8070021Teniposide: overview of its therapeutic potential in adult cancers.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8070021PubMed
3289632Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity.Blut1988https://conductscience.org/library/papers/3289632PubMed
2731312Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2731312PubMed
2661101Clinical pharmacokinetics-pharmacodynamics of anticancer drugs.Clin Pharmacokinet1989https://conductscience.org/library/papers/2661101PubMed
2245178Clinical pharmacokinetics of etoposide during 120 hours continuous infusions in solid tumours.Br J Cancer1990https://conductscience.org/library/papers/2245178PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3598607

GET https://conductscience.org/api/papers/v1/3598607/cited_by?page=2